Phathom Pharmaceuticals | 10-Q:季度報表
Phathom Pharmaceuticals | 8-K:Phathom Pharmicals公佈2024年第一季度財務業績並提供業務最新情況
Phathom Pharmaceuticals | DEF 14A:股東委託書決議
Phathom Pharmaceuticals | DEFA14A:其他
Phathom Pharmaceuticals | ARS:年度報告
Phathom Pharmaceuticals | 4:持股變動聲明-高管 Henderson Molly
Phathom Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(4.8%)
Phathom Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(5.4%)
Phathom Pharmaceuticals | 4:持股變動聲明-高管 Curran Terrie
Phathom Pharmaceuticals | 10-K:年度報表
Phathom Pharmaceuticals | 8-K:Phathom Pharmicals公佈2023年第四季度和全年財務業績並提供業務最新情況
Phathom Pharmaceuticals | 8-K:重大事件
Phathom Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Carlyle Group Inc.(6.1%),Carlyle Holdings I GP Inc.(6.1%)等
Phathom Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Invesco Ltd.(5.5%)
Phathom Pharmaceuticals | 3:首次持股聲明-股東 Medicxi Ventures Management (Jersey) Ltd
Phathom Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Medicxi Ventures Management (Jersey) Limited(13.0%),Medicxi Growth I GP Limited(6.6%)等
Phathom Pharmaceuticals | 4:持股變動聲明-股東 TAKEDA PHARMACEUTICAL CO LTD
Phathom Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(6.6%)
Phathom Pharmaceuticals | 4:持股變動聲明-高管 Nabulsi Azmi
Phathom Pharmaceuticals | 4:持股變動聲明-高管 Curran Terrie
暫無數據